Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[PSA rise after radical prostatectomy].

M Wirth1, M Fröhner

  • 1Klinik und Poliklinik für Urologie, Universitätsklinikum rising dbl quote, left (low)Carl Gustav Carus", Technische Universität Dresden.

Der Urologe. Ausg. A
|February 9, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating the interpretation of neck CT/MRI scans by ChatGPT-4V for detecting primary oropharyngeal squamous cell carcinoma: An exploratory study.

European annals of otorhinolaryngology, head and neck diseases·2026
Same author

[Androgen deprivation therapy of prostate cancer from a geriatric perspective].

Zeitschrift fur Gerontologie und Geriatrie·2025
Same author

Quadrupole Coupling of Circular Rydberg Qubits to Inner Shell Excitations.

Physical review letters·2024
Same author

[Urogeriatric thinking using the example of antiandrogen therapy for prostate cancer].

Urologie (Heidelberg, Germany)·2024
Same author

[Liquid biopsy-a possible key player in immuno-oncology].

HNO·2020
Same author

Lesions of the lateral pterygoid muscle-an overestimated reason for temporomandibular dysfunction: a 3T magnetic resonance imaging study.

International journal of oral and maxillofacial surgery·2020
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
See all related articles

Prostate-specific antigen (PSA) failure after radical prostatectomy occurs in about 35% of prostate cancer patients within 10 years. Early indicators like PSA doubling time help predict recurrence and guide treatment decisions for better outcomes.

Area of Science:

  • Urology
  • Oncology
  • Medical Diagnostics

Context:

  • Radical prostatectomy is a primary treatment for localized prostate cancer.
  • Post-surgical prostate-specific antigen (PSA) monitoring is crucial for detecting recurrence.
  • Understanding PSA failure patterns is key to managing prostate cancer progression.

Purpose:

  • To analyze the incidence and implications of PSA failure post-radical prostatectomy.
  • To identify prognostic factors for clinical recurrence and metastasis.
  • To inform treatment strategies for patients experiencing PSA relapse.

Summary:

  • Approximately 18% of patients experience isolated PSA failure after radical prostatectomy, with a similar rate of clinical recurrence.
  • The 10-year risk of PSA recurrence for clinically localized prostate cancer is around 35%.

Related Experiment Videos

  • PSA relapse often precedes metastases by a median of 8 years, with a median survival of 4-5 years post-metastasis.

    • Impact:

    • Recurrence-free interval, Gleason score, and PSA doubling time are vital for differentiating PSA failure causes.
    • Biopsies are recommended for patients with late PSA relapse ( >2 years) if local radiotherapy is considered.
    • Further clinical trials are needed to optimize hormonal therapy timing (immediate, delayed, intermittent) for individual cases.